Literature DB >> 22201927

Increased levels of hemoglobin and alpha1-microglobulin in Huntington's disease.

Magnus G Olsson1, Sara Davidsson, Zara Din Muhammad, Nayana Lahiri, Sarah J Tabrizi, Bo Akerstrom, Maria Bjorkqvist.   

Abstract

Hemoglobin released from damaged erythrocytes is a major pro-oxidant, generator of free radicals and inflammatory mediator. Huntington's disease is an inherited neurodegenerative disorder characterized by both neurological and systemic abnormalities, in which oxidative stress has been suggested as a possible pathogenic mechanism. In the present work we have investigated levels of hemoglobin and markers of oxidative damage, including the heme- and radical-scavenger alpha1-microglobulin, in plasma and urine samples from two separate sample cohorts, including controls, premanifest gene carriers and subjects at different stages of Huntington's disease. The results show statistically significant increased levels of hemoglobin and alpha1-microglobulin in Huntington's disease urine samples. Interestingly, urine hemoglobin levels correlate with clinical severity. The results suggest that hemolysis may be linked to the pathogenesis of Huntington's disease and that assay of hemoglobin and alpha1-microglobulin may provide biomarkers that are linked to biologically relevant processes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22201927     DOI: 10.2741/E432

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  5 in total

1.  Platelet-derived extracellular vesicles in Huntington's disease.

Authors:  Hélèna L Denis; Jérôme Lamontagne-Proulx; Isabelle St-Amour; Sarah L Mason; Andreas Weiss; Sylvain Chouinard; Roger A Barker; Eric Boilard; Francesca Cicchetti
Journal:  J Neurol       Date:  2018-09-12       Impact factor: 4.849

2.  Disturbed Red Blood Cell Structure and Function: An Exploration of the Role of Red Blood Cells in Neurodegeneration.

Authors:  Giel J C G M Bosman
Journal:  Front Med (Lausanne)       Date:  2018-07-16

Review 3.  A Critical Evaluation of Wet Biomarkers for Huntington's Disease: Current Status and Ways Forward.

Authors:  Edina Silajdžić; Maria Björkqvist
Journal:  J Huntingtons Dis       Date:  2018

4.  rA1M-035, a Physicochemically Improved Human Recombinant α1-Microglobulin, Has Therapeutic Effects in Rhabdomyolysis-Induced Acute Kidney Injury.

Authors:  Bo Åkerström; Lena Rosenlöf; Anneli Hägerwall; Sigurbjörg Rutardottir; Jonas Ahlstedt; Maria E Johansson; Lena Erlandsson; Maria Allhorn; Magnus Gram
Journal:  Antioxid Redox Signal       Date:  2018-04-11       Impact factor: 8.401

5.  α1-Microglobulin Binds Illuminated Flavins and Has a Protective Effect Against Sublethal Riboflavin-Induced Damage in Retinal Epithelial Cells.

Authors:  Jesper Bergwik; Bo Åkerström
Journal:  Front Physiol       Date:  2020-04-02       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.